Vireo Growth (VREOF) Current Deferred Revenue (2020 - 2026)

Vireo Growth (VREOF) reported Current Deferred Revenue of $4.3 million for Q1 2026, up 260.28% on a YoY basis from $1.2 million in Q1 2025, and down 8.51% sequentially from $4.7 million in Q4 2025.

Vireo Growth (VREOF) Current Deferred Revenue (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Current Deferred Revenue data on file, last reported at $4.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue rose 260.28% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 260.28% YoY), and the FY2025 full-year result was $4.7 million, up 346.07% from the prior year.
  • Current Deferred Revenue eased to $4.3 million in Q1 2026, from $4.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.7 million in Q4 2025 to a low of $450334.0 in Q1 2022.
  • A 5-year average of $1.4 million and a median of $833832.0 in 2023 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue increased 13.22% in 2023 and surged 346.07% in 2025, its largest moves.
  • Tracing VREOF's Current Deferred Revenue over 5 years: stood at $684703.0 in 2022, then gained by 21.78% to $833832.0 in 2023, then advanced by 26.36% to $1.1 million in 2024, then surged by 346.07% to $4.7 million in 2025, then fell by 8.51% to $4.3 million in 2026.
  • Business Quant data shows VREOF's Current Deferred Revenue at $4.3 million in Q1 2026, $4.7 million in Q4 2025, and $2.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.30 Mn
Dec 31, 2025 4.70 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.43 Mn
Mar 31, 2025 1.19 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 921,785.00
Jun 30, 2024 821,761.00
Mar 31, 2024 885,696.00
Dec 31, 2023 833,832.00
Sep 30, 2023 732,775.00
Jun 30, 2023 626,689.00
Mar 31, 2023 710,117.00
Dec 31, 2022 684,703.00
Sep 30, 2022 647,208.00
Jun 30, 2022 522,926.00
Mar 31, 2022 450,334.00
Dec 31, 2021 409,627.00
Sep 30, 2021 424,448.00
Jun 30, 2021 374,498.00